title: Systemic sclerosis - focus on dermatological aspects. Part 2: diagnostics, therapy.
abstract: Systemic sclerosis is a chronic inflammatory multiorgan disease which may involve the skin and internal organs to a varying extent. Pathogenetically the vasculature, connective tissue and the immune system are involved in a yet to be defined sequence and impact. Case history and results of physical as well as laboratory examinations will determine individually adapted further organ imaging or invasive procedures. Based on their results therapy is initiated which may include supportive measures such as physiotherapy as well as basic skin care and avoidance of any trauma. Many agents are available for the circulatory problems including Raynaud phenomenon and digital ulcers such as calcium channel blockers, ACE inhibitors and intravenous prostacyclin derivatives, as well as endothelin receptor blockers and phosphodiesterase inhibitors. Immunosuppressive and immunomodulatory agents are of varying efficacy depending on organ involvement. Though various therapeutic measures are available, beneficial effects are limited and associated with various unwanted effects. In any case, the therapy has to be individually adapted to the disease stage and course of the disease.
authors.affiliation: Department of Dermatology, University of Erlangen, Germany. michael.sticherling@uk-erlangen.de
authors.forename: Michael
authors.initials: M
authors.lastname: Sticherling
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D046169:Dermoscopy / Q000639:trends*; D006801:Humans; D007118:Immunoassay / Q000639:trends; D012595:Scleroderma, Systemic / Q000175:diagnosis* / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000639:trends*; D014463:Ultrasonography / Q000639:trends*; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D000305:Adrenal Cortex Hormones; D014665:Vasodilator Agents